Markets:

Overview

News

Currencies

International

Treasuries

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

1.090 +0.070 (+6.86%)

Official Closing Price Updated: 5:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovaBay Pharmaceuticals, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

NovaBay Pharmaceuticals Reports First Quarter 2023 Financial Results

May 11, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals's Earnings: A Preview ↗

May 10, 2023

Via Benzinga

PhaseOne Health Collaborates with Nonprofit Humanitarian Organization to Supply NovaBay Pharmaceuticals’ Phase One® Skin and Wound Cleanser to Ukraine

May 05, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023

May 04, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Earnings Preview: NovaBay Pharmaceuticals ↗

March 29, 2023

Via Benzinga

NovaBay Pharmaceuticals Fulfills $1 Million Order for NeutroPhase® Skin and Wound Cleanser for China Pioneer Pharma Holdings

May 01, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 28, 2023

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 28, 2023

Via Benzinga

NovaBay Pharmaceuticals Announces $3.0 Million Convertible Note Financing

April 27, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 21, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 25, 2023

Tuesday's session saw 286 companies set new 52-week lows.

Via Benzinga

NovaBay Pharmaceuticals Launches DERMAdoctor’s New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC® Network

April 21, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results

March 30, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For March 30, 2023 ↗

March 30, 2023

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.

Via Benzinga

NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023

March 23, 2023

From NovaBay Pharmaceuticals, Inc:

Via Business Wire

Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals’ Avenova.com and Physician-Dispensed Channel

March 14, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health

March 07, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC® Shows on February 7

February 06, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023

January 31, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

PhaseOne Health and NovaBay Pharmaceuticals to Expand Commercial and Collaborative Strategies for the Wound Care Market

January 17, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 14, 2022

We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China

November 29, 2022

From NovaBay® Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema Balm

November 17, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results

November 14, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 16, 2022

On Wednesday, 70 companies set new 52-week lows.

Via Benzinga

NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split

November 14, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For November 14, 2022 ↗

November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.